Publicaciones en colaboración con investigadores/as de University of Calgary (8)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

    Future oncology (London, England), Vol. 19, Núm. 38, pp. 2505-2516

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

    The Lancet, Vol. 399, Núm. 10342, pp. 2200-2211

2018

  1. Regional variation of Guillain-Barré syndrome

    Brain, Vol. 141, Núm. 10, pp. 2866-2877

2017

  1. Composing a new song for trials: The Standardized Outcomes in Nephrology (SONG) initiative

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 12, pp. 1963-1966

  2. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

    Journal of the Peripheral Nervous System, Vol. 22, Núm. 2, pp. 68-76

1996

  1. Systemic aluminum toxicity: Effects on bone, hematopoietic tissue, and kidney

    Journal of Toxicology and Environmental Health - Part A, Vol. 48, Núm. 6, pp. 649-665